Meet BrosMed at EuroPCR 2024: Advancing Cardiovascular Intervention
Release time:
2024-04-18
We are thrilled to announce BrosMed’s participation in EuroPCR 2024, one of the leading events in interventional cardiovascular medicine, taking place from May 14th to 17th at Palais des Congrès, Paris.
We are thrilled to announce BrosMed’s participation in EuroPCR 2024, one of the leading events in interventional cardiovascular medicine, taking place from May 14th to 17th at Palais des Congrès, Paris.
At this year’s exhibition, BrosMed is excited to showcase our latest innovation, especially the Toolkit for Complex PCI. Designed to meet the evolving needs of interventional cardiologists, this toolkit offers a comprehensive solution for challenging procedures, allowing for greater precision and improved patient outcomes.
Visit our booth (M22, Level-2-hall-maillot) to explore the features and benefits of BrosMed’s cardiovascular solutions, and engage with our team to learn how it can enhance your practice. Join us in shaping the future of interventional cardiology.
What’s more, we are having a symposium with the theme EVOLUTION OF COMPLEX PCI: CROSS, MODIFY IT, AND BE PRECISE! Clinical experts from Italy, Belgium, UK and India will donate captivating presentations, insightful talks, and a glimpse into our cutting-edge Live-in-a-box. We’ll delve into the evolution of complex PCI strategies, precision techniques, and how they impact patient outcomes.
Stay tuned for more updates and insights as we approach EuroPCR 2024. We look forward to welcoming you at our booth!
ABOUT BROSMED MEDICAL
Founded in 2012, BrosMed is a leading medical device multinational company specializing in R&D, production, and global sales of high-performance intravascular interventional medical devices. We have operated four R&D centers (Labs), and 2 manufacturing centers around China, Europe, and Asia Pacific. BrosMed has more than 20 product series and 360+ product registration certificates worldwide.
Previous Article
Next Article
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
